Submitted by Anonymous (not verified) on 27 May 2026 - 14:25
Human medicines European public assessment report (EPAR): Xenleta, lefamulin, Date of authorisation: 27/07/2020, Revision: 3, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Xenleta, lefamulin, Date of authorisation: 27/07/2020, Revision: 3, Status: Authorised